The Biotech Takeout Menu Gets Pricier

[ad_1] Markets Heard on the Street Biotech investments are typically risky, but companies regarded as natural takeover targets for big pharma are outperforming [ad_2] Source link

After Zero-Covid, China’s Health Industry Faces Titanic Shift

[ad_1] Markets Heard on the Street As the country reopens, healthcare spending patterns will shift rapidly—creating new winners and losers [ad_2] Source link

GSK, Sanofi Shares Jump After U.S. Judge Dismisses Zantac Lawsuit

[ad_1] Business Health Care Health Tens of thousands of lawsuits alleged that the heartburn treatment could cause cancer [ad_2] Source link